chr5-73051352-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138782.3(FCHO2):āc.943A>Gā(p.Ile315Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000072 in 1,527,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138782.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO2 | NM_138782.3 | c.943A>G | p.Ile315Val | missense_variant | 12/26 | ENST00000430046.7 | NP_620137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO2 | ENST00000430046.7 | c.943A>G | p.Ile315Val | missense_variant | 12/26 | 1 | NM_138782.3 | ENSP00000393776.2 | ||
FCHO2 | ENST00000512348.5 | c.844A>G | p.Ile282Val | missense_variant | 11/25 | 2 | ENSP00000427296.1 | |||
FCHO2 | ENST00000503302.1 | n.253A>G | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151980Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000666 AC: 1AN: 150200Hom.: 0 AF XY: 0.0000126 AC XY: 1AN XY: 79322
GnomAD4 exome AF: 0.00000654 AC: 9AN: 1375186Hom.: 0 Cov.: 27 AF XY: 0.00000736 AC XY: 5AN XY: 678988
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74232
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2024 | The c.943A>G (p.I315V) alteration is located in exon 12 (coding exon 12) of the FCHO2 gene. This alteration results from a A to G substitution at nucleotide position 943, causing the isoleucine (I) at amino acid position 315 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at